# Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation

> **NCT01719367** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 38 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT01719367
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719367, "Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01719367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*